Related by context. Frequent words. (Click for all words.) 55 ImmunoCellular Therapeutics 54 Phase Ib clinical 54 Phase Ib II 53 Preclinical Development 52 AVAX 51 Phase IIb trials 50 IMC #B 50 peginesatide 49 EORTC NCI AACR 49 Emisphere Technologies 49 CALGB 49 SAR# [004] 47 ASHG 47 #th Annual Interscience 46 EORTC 46 anticancer compound 46 JAK1 46 http:/profnet.prnewswire.com/ud public.jsp?useridShuan 45 Principle Investigator 45 vismodegib 45 EndoTAG TM -1 45 Endovasc 45 ACNP 44 MD FRCP 44 ESBATech 44 BAY #-# 44 Mipomersen 44 INGN 44 http:/profnet.prnewswire.com/Subscriber/ExpertProJim Argue 43 BIO InvestorForum 43 ASH Annual Meeting 43 Frankfurt Xetra Exchange NG6 43 ViiV Healthcare 43 WILEX 43 AEG# 43 GSK# [001] 42 JMP Securities Healthcare 42 novel anticancer 42 ANAVEX #-# [003] 42 Transcatheter Cardiovascular Therapeutics TCT 42 Molecular Targets 42 https:/profnet.prnewswire.com/Subscriber/ExpertPrBANGKOK Thomson Financial 42 PhytoMedical 42 Karo Bio 42 Virulizin R 42 Breast Cancer Symposium 41 ISTODAX 41 Nautilus Biotech 41 PARP inhibitor 41 MORAb 41 Pharmacoeconomics 41 M.Sc. P.Eng 41 Yours sincerely 41 #st Annual Meeting 41 potent inhibitor 41 StemEx 40 Corresponding author 40 nucleoside reverse transcriptase inhibitor 39 B.Sc. P.Geo 39 Dywedodd 39 4SC AG 39 selective inhibition 39 GPC Biotech 39 Principal Scientist 39 PAION 39 DeveloGen 39 Elafin 38 BioInvent 38 Biotest 38 Principal Investigator 38 Poster Session 38 Storage Visions Conference 38 CFO Quick Facts 37 Summarising 37 Orexo 37 P.Geol 37 Biofrontera 37 MediGene 37 Ali Al Sayegh 37 GCSF 36 CE Unterberg Towbin Emerging 36 MIV 36 Opportunistic Infections CROI 36 cytostatic 36 Principal Executive Officer 35 ACC.# 35 Updates Shareholders 35 Group ECOG 35 Genome Biology 35 Digestive Disease Week DDW 35 HE Saeed 35 PARP inhibitors 35 Opening Remarks 35 ICSS 35 etquot 34 bin Haji Mohd 34 JAR opposite 34 Deliver Keynote Address 34 chemokine 34 Unfair challenge 34 holds BSc